Diploma (LON:DPLM) Sets New 1-Year High Following Insider Buying Activity

Diploma PLC (LON:DPLM) shares hit a new 52-week high during mid-day trading on Thursday after an insider bought additional shares in the company. The company traded as high as GBX 7,775 and last traded at GBX 7,760, with a volume of 1460091 shares trading hands. The stock had previously closed at GBX 7,620.

Specifically, insider Katie Bickerstaffe  bought 246 shares of Diploma stock in a transaction on Wednesday, September 23rd. The shares were purchased at an average price of GBX 7,696 per share, for a total transaction of £18,932.16.

Analyst Ratings Changes

A number of research analysts have recently commented on DPLM shares. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 7,400 target price on shares of Diploma in a research note on Tuesday, September 8th. JPMorgan Chase & Co. boosted their target price on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the company an “overweight” rating in a report on Monday, August 24th. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 7,000 target price on shares of Diploma in a research report on Friday, May 29th. Finally, Berenberg Bank reiterated a “buy” rating and issued a GBX 9,000 price target on shares of Diploma in a research note on Monday, July 20th. Six investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Diploma currently has a consensus rating of “Moderate Buy” and an average target price of GBX 7,400.

Diploma Trading Up 1.9%

The firm has a 50-day moving average price of GBX 7,333.91 and a 200-day moving average price of GBX 6,869.68. The company has a debt-to-equity ratio of 47.65, a quick ratio of 0.80 and a current ratio of 2.06. The stock has a market cap of £10.41 billion, a PE ratio of 55.15, a price-to-earnings-growth ratio of 2.82 and a beta of 0.92.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.